Jack Bendheim is CEO & President +1 at PHIBRO ANIMAL HEALTH CORP (PAHC). They have made 40 open-market trades across 1 company since 2014, most recently 2026-08-06.
CIK 0001241560
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 40 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PAHC | 26,640 | $1.0M |
| ERS | 6,000 | $42K |
| Total | $1.1M |
Shares reported on the most recent Form 4, priced at the 2026-08-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 50% | 67% |
| Avg Move | -2.1% | +2.2% | -10.5% |
| Scored | 12 | 12 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PAHC | SELL · 10b5-1 | 2026-05-05 | 2026-05-07 | $54.61 | $1.0M | -19.0% | -24.1% | -13.6% |
| PAHC | SELL · 10b5-1 | 2026-04-28 | 2026-04-30 | $53.86 | $1.1M | -33.1% | -45.4% | -32.5% |
| PAHC | SELL · 10b5-1 | 2026-04-21 | 2026-04-23 | $54.79 | $1.2M | +3.6% | -38.1% | -37.9% |
| PAHC | SELL · 10b5-1 | 2026-04-14 | 2026-04-16 | $56.89 | $1.2M | -0.7% | -37.8% | -38.7% |
| PAHC | SELL · 10b5-1 | 2026-03-30 | 2026-03-31 | $53.75 | $1.5M | +6.5% | -4.8% | -43.0% |
| PAHC | SELL · 10b5-1 | 2026-03-24 | 2026-03-26 | $55.21 | $2.3M | +6.2% | +1.6% | -43.2% |
| PAHC | SELL · 10b5-1 | 2026-03-17 | 2026-03-19 | $52.39 | $2.4M | +6.2% | +8.5% | -40.8% |
| PAHC | SELL | 2026-03-13 | 2026-03-16 | $48.91 | $258K | +8.8% | +7.3% | -36.9% |
| PAHC | SELL | 2026-02-24 | 2026-02-26 | $52.27 | $1.1M | -6.1% | -0.7% | -38.8% |
| PAHC | SELL · 10b5-1 | 2026-02-10 | 2026-02-11 | $51.77 | $3.7M | -0.7% | -4.5% | -29.4% |
| PAHC | SELL | 2026-02-05 | 2026-02-09 | $48.38 | $5.4M | +1.5% | -3.7% | -30.1% |
| PAHC | SELL | 2026-02-03 | 2026-02-05 | $41.39 | $545K | +0.7% | -3.9% | +15.5% |
| PAHC | SELL · 10b5-1 | 2026-01-23 | 2026-01-27 | $40.55 | $50K | +33.9% | +38.0% | +41.7% |
| PAHC | SELL · 10b5-1 | 2026-01-21 | 2026-01-22 | $41.82 | $1.2M | +0.1% | +24.9% | +30.8% |
| PAHC | SELL | 2026-01-13 | 2026-01-15 | $40.31 | $570K | -3.1% | +30.5% | +37.3% |
| PAHC | SELL · 10b5-1 | 2026-01-07 | 2026-01-08 | $40.09 | $13K | +5.6% | +30.6% | +47.7% |
| PAHC | SELL · 10b5-1 | 2025-12-08 | 2025-12-10 | $40.09 | $386K | -6.0% | -2.0% | +25.3% |
| PAHC | SELL · 10b5-1 | 2025-11-04 | 2025-11-06 | $42.12 | $530K | +0.5% | -7.2% | -5.0% |
| PAHC | SELL · 10b5-1 | 2025-10-28 | 2025-10-30 | $41.43 | $875K | +9.2% | -1.8% | -6.6% |
| PAHC | SELL · 10b5-1 | 2025-10-17 | 2025-10-21 | $40.37 | $1.3M | +1.5% | -1.5% | -0.9% |
| PAHC | SELL · 10b5-1 | 2025-09-18 | 2025-09-22 | $40.26 | $565K | +1.8% | +4.9% | -1.3% |
| PAHC | SELL · 10b5-1 | 2025-09-09 | 2025-09-11 | $40.56 | $1.6M | -5.8% | -10.3% | -2.2% |
| PAHC | SELL · 10b5-1 | 2018-09-12 | 2018-09-14 | $45.04 | $23K | -1.8% | -1.8% | -24.9% |
| PAHC | SELL | 2018-09-05 | 2018-09-06 | $47.14 | $943K | -5.9% | -7.7% | -29.0% |
| PAHC | SELL | 2018-08-21 | 2018-08-23 | $49.99 | $2.0M | -4.5% | -14.9% | -32.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.